Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Banco de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Am J Physiol Heart Circ Physiol ; 289(4): H1442-7, 2005 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-15964921

RESUMEN

Carbon monoxide (CO) and nitric oxide (NO) can be involved in the regulation of cerebral circulation. Inhibition of production of either one of these gaseous intercellular messengers inhibits newborn pig cerebral arteriolar dilation to the excitatory amino acid glutamate. Glutamate can increase NO production. Therefore, the present study tests the hypothesis that NO, which is increased by glutamate, stimulates the production of CO by cerebral microvessels. Experiments used freshly isolated cerebral microvessels from piglets that express only heme oxygenase-2 (HO-2). CO production was measured by gas chromatography-mass spectrometry. Although inhibition of nitric oxide synthase (NOS) with N(omega)-nitro-l-arginine (l-NNA) did not alter basal HO-2 catalytic activity or CO production, l-NNA blocked glutamate stimulation of HO-2 activity and CO production. Furthermore, the NO donor sodium nitroprusside mimicked the actions of glutamate on HO-2 and CO production. The action of NO appears to be via cGMP because 8-bromo-cGMP mimics and 1H-[1,2,4]oxadiazole-[4,3-a]quinoxalin-1-one (ODQ) blocks glutamate stimulation of CO production and HO-2 catalytic activity. Inhibitors of neither casein kinase nor phosphotidylinositol 3-kinase altered HO-2 catalytic activity. Conversely, inhibition of calmodulin with calmidazolium chloride blocked glutamate stimulation of CO production and reduced HO-2 catalytic activity. These data suggest that glutamate may activate NOS producing NO that leads to CO synthesis via a cGMP-dependent elevation of HO-2 catalytic activity. These results are consistent with the findings in vivo that either HO or NOS inhibition blocks cerebrovascular dilation to glutamate in piglets.


Asunto(s)
Monóxido de Carbono/metabolismo , Circulación Cerebrovascular/fisiología , Óxido Nítrico/metabolismo , Animales , Animales Recién Nacidos , Inhibidores Enzimáticos/farmacología , Guanilato Ciclasa/antagonistas & inhibidores , Imidazoles/farmacología , Microcirculación/fisiología , Donantes de Óxido Nítrico/farmacología , Óxido Nítrico Sintasa/antagonistas & inhibidores , Nitroarginina/farmacología , Nitroprusiato/farmacología , Oxadiazoles/farmacología , Quinoxalinas/farmacología , Porcinos
2.
Am J Physiol Heart Circ Physiol ; 285(1): H74-80, 2003 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-12623781

RESUMEN

Dilation of piglet pial arterioles to glutamate involves carbon monoxide (CO) produced from heme by heme oxygenase-2 (HO-2). Piglet cerebral microvessels and endothelial and smooth muscle cells grown on microcarrier beads were used to address the hypothesis that glutamate increases endothelial CO production by increasing HO-2 catalytic activity. CO was measured by gas chromatography/mass spectrometry. Glutamate increased CO production from endogenous heme by cerebral microvessels, endothelial cells, and smooth muscle cells. Glutamate increased the conversion of exogenous heme to CO. Protein tyrosine kinase inhibition blocked glutamate stimulation of CO production. Inhibition of protein tyrosine phosphatases stimulated CO production. Conversely, neither phorbol myristate acetate nor H-7 changed glutamate stimulation of CO production. The mechanism of HO-2 stimulation by glutamate appears to be independent of cytosolic Ca, because stimulation of CO production by glutamate was the same in Careplete medium, Ca-free medium with ionomycin, and Careplete medium with ionomycin. Therefore, glutamate appears to increase HO-2 catalytic activity in cerebral microvessels via a tyrosine kinase mediated pathway.


Asunto(s)
Vasos Sanguíneos/metabolismo , Química Encefálica/efectos de los fármacos , Monóxido de Carbono/metabolismo , Ácido Glutámico/farmacología , Animales , Vasos Sanguíneos/efectos de los fármacos , Vasos Sanguíneos/enzimología , Señalización del Calcio/efectos de los fármacos , Señalización del Calcio/fisiología , Capilares/efectos de los fármacos , Capilares/enzimología , Capilares/metabolismo , Células Cultivadas , Endotelio Vascular/citología , Endotelio Vascular/efectos de los fármacos , Endotelio Vascular/enzimología , Inhibidores Enzimáticos/farmacología , Antagonistas de Aminoácidos Excitadores/farmacología , Cromatografía de Gases y Espectrometría de Masas , Hemo Oxigenasa (Desciclizante)/metabolismo , Microesferas , Músculo Liso Vascular/citología , Músculo Liso Vascular/efectos de los fármacos , Músculo Liso Vascular/enzimología , Proteínas Tirosina Fosfatasas/antagonistas & inhibidores , Proteínas Tirosina Quinasas/antagonistas & inhibidores , Porcinos
3.
Am J Physiol Heart Circ Physiol ; 285(1): H292-7, 2003 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-12623784

RESUMEN

Carbon monoxide (CO) is produced from heme by heme oxygenase-2 (HO-2) in cerebral blood vessels. Gas chromatography-mass spectrometry was used on piglet cerebral microvessels to address the hypothesis that CO production is regulated by heme delivery and HO-2 catalytic activity. CO production appears to be substrate limited because heme and its precursor aminolevulinate increase CO production. Ionomycin also increases CO production. However, CO production from exogenous heme was the same in Ca-replete medium, Ca-free medium with ionomycin, and Ca-replete medium with ionomycin. Phorbol myristate acetate increases CO production but does not change the catalytic activity of HO-2. Also, the protein kinase C inhibitor 1-(5-isoquinolinylsulfonyl)-2-methylpiperazine has no effect on the HO-2 catalytic activity. Protein tyrosine kinase inhibition reduces HO-2 catalytic activity. Inhibition of protein tyrosine phosphatases increased HO-2 catalytic activity. Therefore, regulation of CO production by cerebral microvessels can include changing heme availability and HO-2 catalytic activity. HO-2 catalytic activity is stimulated by tyrosine phosphorylation.


Asunto(s)
Animales Recién Nacidos/fisiología , Monóxido de Carbono/metabolismo , Circulación Cerebrovascular/fisiología , 1-(5-Isoquinolinesulfonil)-2-Metilpiperazina/farmacología , Ácido Aminolevulínico/farmacología , Animales , Calcio/farmacología , Señalización del Calcio/fisiología , Capilares/enzimología , Capilares/metabolismo , Capilares/fisiología , Catálisis , Citosol/metabolismo , Inhibidores Enzimáticos/farmacología , Genisteína/farmacología , Hemo/metabolismo , Hemo Oxigenasa (Desciclizante)/metabolismo , Técnicas In Vitro , Ionomicina/farmacología , Ionóforos/farmacología , Fosforilación , Fármacos Fotosensibilizantes/farmacología , Porcinos , Acetato de Tetradecanoilforbol/farmacología , Tirfostinos/farmacología , Vanadatos/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA